Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

DGAP-Adhoc: PAUL HARTMANN AG: PAUL HARTMANN AG (ISIN DE0007474041): Ergebnisprognose Geschäftsjahr 2022
DGAP-Adhoc: PAUL HARTMANN AG: PAUL HARTMANN AG (ISIN DE0007474041): Ergebnisprognose Geschäftsjahr 2022
DGAP-Adhoc: PAUL HARTMANN AG: PAUL HARTMANN AG (ISIN DE0007474041): Ergebnisprognose Geschäftsjahr 2022
EQS-News: Straumann Group Capital Markets Day 2021
EQS-News: Straumann Group Capital Markets Day 2021
EQS-News: Straumann Group Capital Markets Day 2021
DGAP-News: M1 Kliniken AG weiterhin erfolgreich im 4. Quartal 2021
DGAP-News: M1 Kliniken AG weiterhin erfolgreich im 4. Quartal 2021
DGAP-News: M1 Kliniken AG weiterhin erfolgreich im 4. Quartal 2021
DGAP-News: M1 Kliniken AG continues successful development in Q4 2021
DGAP-News: M1 Kliniken AG continues successful development in Q4 2021
DGAP-News: M1 Kliniken AG continues successful development in Q4 2021
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
DGAP-News: MicroVision Inc.: MicroVision to Participate in LiDAR Sensor Standards Consortium
DGAP-News: MicroVision Inc.: MicroVision to Participate in LiDAR Sensor Standards Consortium
DGAP-News: MicroVision Inc.: MicroVision to Participate in LiDAR Sensor Standards Consortium
DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
Is This Telehealth Stock a Buy After the Recent Pullback?: https://www.marketbeat.com/logos/articles/med_20240719104001_is-this-telehealth-stock-a-buy-after-the-recent-pu.jpg
Is This Telehealth Stock a Buy After the Recent Pullback?

Hims & Hers Health, Inc. (NYSE: HIMS) is a prominent player in the telehealth sector, which is part of the larger healthcare sector.  The company has garnered significant attention from

Why This Healthcare Stock is a Strong Buy Despite Headwinds: https://www.marketbeat.com/logos/articles/med_20240716075118_chart-unh-7162024ver001.png
Why This Healthcare Stock is a Strong Buy Despite Headwinds

UnitedHealth Group (NYSE: UNH) has headwinds, but its healthcare business and operational quality offset them, setting the stock to hit new all-time highs. The primary culprit is the recent

Strategic Buy Lights Up This Biotech Stock: Time to Invest?: https://www.marketbeat.com/logos/articles/med_20240715092117_chartm-ilmn.jpg
Strategic Buy Lights Up This Biotech Stock: Time to Invest?

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. This comes after its divestiture and spin-off of

Top 4 Must-Have Healthcare Stocks for Long-Term Growth: https://www.marketbeat.com/logos/articles/med_20240711100558_top-4-must-have-healthcare-stocks-for-long-term-gr.jpg
Top 4 Must-Have Healthcare Stocks for Long-Term Growth

The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging

This Tech Stock Can Set a Multiyear High with AI-Powered Growth: https://www.marketbeat.com/logos/articles/med_20240710082907_chart-sgh-7102024ver001.png
This Tech Stock Can Set a Multiyear High with AI-Powered Growth

SMART Global Holdings' (NASDAQ: SGH) repositioning efforts have set it up to achieve record-high share prices soon. The company’s Q3 results aren’t perfect, but include critical details that

Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market: https://www.marketbeat.com/logos/articles/med_20240630174256_charty-lly.jpg
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market

Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. Mounjaro is prescribed for Type 2 diabetes but is

HealthEquity Stock: Leading Health Savings Account Investment: https://www.marketbeat.com/logos/articles/med_20240609114559_chart-hqy.jpg
HealthEquity Stock: Leading Health Savings Account Investment

HealthEquity Inc (NASDAQ: HQY) is one of the nation’s largest providers of health savings accounts (HSA) and consumer-directed benefits (CDB) services. Its platform enables individuals to open

Centene Reaffirms Guidance, But Is it Too Late?: https://www.marketbeat.com/logos/articles/med_20240602155058_chart-cnc.jpg
Centene Reaffirms Guidance, But Is it Too Late?

Managed care health insurance company Centene Inc. (NYSE: CNC) recently saw its share rebound after reaffirming its guidance. This move came just after UnitedHealth Group Inc. (NYSE: UNH) made

Is Cigna Group the Nation's Best-Run Health Insurance Company?: https://www.marketbeat.com/logos/articles/med_20240525153829_chart-ci.jpg
Is Cigna Group the Nation's Best-Run Health Insurance Company?

Health insurance companies in the medical sector have not fared well in 2024. Medicare Advantage (MA) plans were a bountiful source of income until the second half of 2023. Humana Inc. (NYSE: HUM)

Medtronic Dips: Is Now the Time to Buy?: https://www.marketbeat.com/logos/articles/med_20240523121523_chart-mdt-5232024ver001.png
Medtronic Dips: Is Now the Time to Buy?

Shares of Medtronic (NYSE: MDT) are falling following its FQ4 release and guidance, opening up a potential buying opportunity. The question is whether its value, yield, balance sheet and cash flow

2 Stocks Providing Medical Insurance for Your Pets: https://www.marketbeat.com/logos/articles/med_20240519155501_chart-trup.jpg
2 Stocks Providing Medical Insurance for Your Pets

The pandemic triggered a surge in pet ownership as social distancing and lockdowns resulted in the need for companionship for many individuals and families. Anyone who owns a dog or cat can

CVS Health Stock Has a Silver Lining Called Value: https://www.marketbeat.com/logos/articles/med_20240519153028_chartzy-cvs.jpg
CVS Health Stock Has a Silver Lining Called Value

Integrated healthcare retailer and insurer CVS Health Co. (NYSE: CVS) stock presents a value not seen in years. The medical sector giant saw its shares punished on its Q1 2024 top and bottom line

Undervalued UnitedHealth Group Won’t Be For Long: https://www.marketbeat.com/logos/articles/med_20240416091545_chart-unh-4162024ver001.png
Undervalued UnitedHealth Group Won’t Be For Long

UnitedHealth Group's (NYSE: UNH) Q1 results were better than expected for two reasons: First, the stock price is now rebounding from long-term lows and deep value territory with ample upside

Novo Nordisk Arms Wegovy to Be a Triple Threat: https://www.marketbeat.com/logos/articles/med_20240414165029_charts-nvo.jpg
Novo Nordisk Arms Wegovy to Be a Triple Threat

Ozempic usage for weight loss has gone viral, making it the highest revenue-generating drug for Novo Nordisk AV/S (NYSE: NVO). Originally purposed for Type 2 diabetes, the skyrocketing off-label

DexCom Stock Gains from GLP-1 Diabetic Users: https://www.marketbeat.com/logos/articles/med_20240331131923_chart-dxcm.jpg
DexCom Stock Gains from GLP-1 Diabetic Users

DexCom Inc. (NASDAQ: DXCM) is a leading medical device company in the medical sector that specializes in continuous glucose monitoring (CGM) systems. People with diabetes use CGM systems to

MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System: https://www.irw-press.at/prcom/images/messages/2024/73936/14032024_EN_Medmira.001.png
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System

Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent (number 2,949,634) for its new innovative and quantitative test

MedMira erhält kanadisches Patent für sein einzigartiges quantitatives Diagnosesystem: https://www.irw-press.at/prcom/images/messages/2024/73936/14032024_DE_Medmira.001.png
MedMira erhält kanadisches Patent für sein einzigartiges quantitatives Diagnosesystem

Halifax, Nova Scotia, 13. März 2024 - Heute gibt MedMira Inc. (MedMira) (TSXV: MIR) den Erhalt eines kanadischen Patents (Nummer 2.949.634) für sein neues innovatives und quantitatives